DE602004015141D1 - Modifizierte ganzzell-, zellextrakt- und omv-basierte impfstoffe - Google Patents

Modifizierte ganzzell-, zellextrakt- und omv-basierte impfstoffe

Info

Publication number
DE602004015141D1
DE602004015141D1 DE602004015141T DE602004015141T DE602004015141D1 DE 602004015141 D1 DE602004015141 D1 DE 602004015141D1 DE 602004015141 T DE602004015141 T DE 602004015141T DE 602004015141 T DE602004015141 T DE 602004015141T DE 602004015141 D1 DE602004015141 D1 DE 602004015141D1
Authority
DE
Germany
Prior art keywords
vaccines
zelextract
omv
whole cell
based vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004015141T
Other languages
English (en)
Inventor
Andrew R Gorringe
Karen M Reddin
Scott D Gray-Owen
Ian C Boulton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Protection Agency
Original Assignee
Health Protection Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Protection Agency filed Critical Health Protection Agency
Publication of DE602004015141D1 publication Critical patent/DE602004015141D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE602004015141T 2003-10-09 2004-10-08 Modifizierte ganzzell-, zellextrakt- und omv-basierte impfstoffe Active DE602004015141D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0323709.6A GB0323709D0 (en) 2003-10-09 2003-10-09 Modified whole cell,cell extract and omv-based vaccines
PCT/GB2004/004274 WO2005035733A2 (en) 2003-10-09 2004-10-08 Modified whole cell, cell extract and omv-based vaccines

Publications (1)

Publication Number Publication Date
DE602004015141D1 true DE602004015141D1 (de) 2008-08-28

Family

ID=29433617

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004015141T Active DE602004015141D1 (de) 2003-10-09 2004-10-08 Modifizierte ganzzell-, zellextrakt- und omv-basierte impfstoffe

Country Status (12)

Country Link
US (1) US20070154495A1 (de)
EP (1) EP1687011B1 (de)
JP (1) JP2007508537A (de)
AT (1) ATE401091T1 (de)
AU (1) AU2004279990B2 (de)
CA (1) CA2541834C (de)
DE (1) DE602004015141D1 (de)
DK (1) DK1687011T3 (de)
ES (1) ES2310753T3 (de)
GB (1) GB0323709D0 (de)
PT (1) PT1687011E (de)
WO (1) WO2005035733A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2494865A4 (de) 2009-09-01 2014-05-14 Aeon Medix Inc Aus der darmflora gewonnene extrazelluläre vesikel sowie verfahren zur suche nach einem krankheitsmodell, impfstoff sowie kandidatenstoff und diagnoseverfahren dafür
WO2011027956A2 (ko) 2009-09-04 2011-03-10 주식회사이언메딕스 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델
WO2011043538A2 (ko) * 2009-10-08 2011-04-14 주식회사이언메딕스 실내 공기유래 세포밖 소포체를 포함하는 조성물 및 이의 용도
JP2011169834A (ja) * 2010-02-19 2011-09-01 Kansai Bunri Sogo Gakuen 病原性グラム陰性細菌由来脂質小胞の検出方法および検出システム
KR20160101521A (ko) * 2015-02-17 2016-08-25 이화여자대학교 산학협력단 세균 유래 세포밖 소포체를 이용한 호흡기 염증성 질환의 진단방법
WO2018042015A1 (en) * 2016-09-02 2018-03-08 Glaxosmithkline Biologicals Sa Vaccines for neisseria gonorrhoeae
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558677B2 (en) * 1996-10-15 2003-05-06 Wendell D. Zollinger Vaccine against gram negative bacteria
GB0130123D0 (en) * 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation
KR101239242B1 (ko) * 2002-08-02 2013-03-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 항원 조합물을 포함하는 나이세리아 백신 조성물

Also Published As

Publication number Publication date
JP2007508537A (ja) 2007-04-05
CA2541834C (en) 2012-09-04
EP1687011B1 (de) 2008-07-16
DK1687011T3 (da) 2008-11-10
AU2004279990A1 (en) 2005-04-21
ATE401091T1 (de) 2008-08-15
EP1687011A2 (de) 2006-08-09
PT1687011E (pt) 2008-10-28
AU2004279990B2 (en) 2010-04-01
CA2541834A1 (en) 2005-04-21
GB0323709D0 (en) 2003-11-12
US20070154495A1 (en) 2007-07-05
ES2310753T3 (es) 2009-01-16
WO2005035733A3 (en) 2005-12-29
WO2005035733A2 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
EA201000424A1 (ru) Антитела к il-23
EA200602137A1 (ru) Гидрогелевые препараты интерферона
ATE331530T1 (de) Proteasom-influenzavirus-impfstoffzusammensetzu g
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
CR8231A (es) Anticuerpos rg1 y uso de los mismos
DE60043708D1 (de) Verfahren zur erhaltung zellimmuneantworten gegen proteinen
CR7875A (es) Variantes de inmunoglobina y usos de esto
MXPA02005639A (es) Induccion de respuestas celulares iinmunologicas al virus de papiloma humano y utilizacion de composiciones de peptidos y acidos nucleico.
MA33757B1 (fr) Protéines de liaison à l'antigène de l'il-23 humaine
BRPI0607605A2 (pt) moléculas imunogênicas
HK1121174A1 (en) Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and their use
EA200870129A1 (ru) Человеческие антитела против il-23, композиции, способы и применение
UA93855C2 (ru) Вакцина, способствует росту, базирующейся ha нейтрализующем эпитопе
NO20062044L (no) Piscirickettsia salmonis-antigener og anvendelse derav
WO2007016185A3 (en) Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination
ATE513561T1 (de) Veränderung des th1/th2-gleichgewichts in spalt- grippeimpfstoffen mit adjuvantien
EA200600065A2 (ru) Гидрофобные композиционные и сыпучие материалы, их применение
ATE460176T1 (de) Mikrosomvakzin
RU2014135406A (ru) Модифицированные эпитопы для усиления ответов cd4+ т-клеток
DK1572087T3 (da) Antistoffer med cancerantigen TMEFF2 og anvendelser deraf
WO2023094713A3 (en) Coronavirus vaccine
BR112022016456A2 (pt) Formulações de anticorpos anti-tslp humanos e métodos de uso dos mesmos
DE602004015141D1 (de) Modifizierte ganzzell-, zellextrakt- und omv-basierte impfstoffe
EA200701166A1 (ru) Альфа-тимозиновые пептиды в качестве адъювантов противораковых вакцин
EA200970731A1 (ru) Рекомбинантные антигены цитомегаловируса человека (hcmv)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition